Premium
Scholar Rock Holdings Corporation (SRRK)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States.... Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.51 | 4.21787709497 | 35.8 | 38.15 | 33.6041 | 990624 | 36.39844714 | CS |
| 4 | 4.83 | 14.8706896552 | 32.48 | 38.15 | 30.965 | 1469665 | 34.96028101 | CS |
| 12 | 6.68 | 21.8086842964 | 30.63 | 38.15 | 28.29 | 1229272 | 32.81214439 | CS |
| 26 | -2.41 | -6.06747230614 | 39.72 | 46.81 | 22.71 | 1169903 | 33.84862008 | CS |
| 52 | 28.81 | 338.941176471 | 8.5 | 46.81 | 6.76 | 1294950 | 30.20431683 | CS |
| 156 | 29.02 | 350.060313631 | 8.29 | 46.81 | 5.56 | 784823 | 21.8328597 | CS |
| 260 | 21.28 | 132.751091703 | 16.03 | 70 | 4.325 | 718879 | 23.6161324 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
